This inventor holds 3 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Innovations of Feng Wang in Pharmaceutical Chemistry
Introduction
Feng Wang is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel carboxylic acid compounds. With a total of 3 patents to his name, his work has implications for the treatment of thrombotic diseases.
Latest Patents
Feng Wang's latest patents include a carboxylic acid compound having a condensed ring and its pharmacologically acceptable salts. These compounds exhibit superior GPIIb/IIIa antagonism in mammals, including humans. They can be administered orally, have a long life in blood, and demonstrate low toxicity with fewer side effects. This makes them extremely useful for the prophylaxis and treatment of thrombotic diseases and other related conditions.
Career Highlights
Feng Wang is currently associated with The Green Cross Corporation, where he continues to innovate in the pharmaceutical sector. His research focuses on creating compounds that can improve patient outcomes in various medical conditions.
Collaborations
Feng Wang has worked alongside notable colleagues such as Norifumi Nakamura and Shinichiro Ono. Their collaborative efforts have contributed to advancements in the field of pharmaceutical research.
Conclusion
Feng Wang's contributions to pharmaceutical chemistry through his innovative patents highlight the importance of research in developing effective treatments for serious health conditions. His work continues to pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile